Catalog: | C-EL-1867T |
Product Type: | Test kit |
Size: | 96 tests |
Principle: | Solid Phase Sandwich ELISA |
Conjugation: | HRP |
Species: | Human |
Detection range: | 43.75-2800 pg/mL |
Sensitivity: | 17.6 pg/mL |
Specificity: | Recognizes both recombinant and natural Human MMP-8 |
Interference: | Preparations of the factors listed below at 10 ng/mL in a mid-range recombinant human MMP8 control were assayed for interference. No significant interference was observed. |
Sample type: | Serum |
Test type: | Quantitative |
Analysis mode: | ELISA |
Shipping: | This ELISA Kit is shipped at ambient temperature. |
Storage: | 2-8℃ |
Full name: | matrix metallopeptidase 8 |
This MMP-8 ELISA Kit, Human is an enzyme-linked immunosorbent assay for the quantitative measurement of Human MMP-8 protein in Serum . It contains recombinant Human MMP-8, and antibodies raised against the recombinant protein. This ELISA kit is complete and ready-to-use.Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases that degrade components of the extracellular matrix (ECM) and play essential roles in various physiological processes such as morphogenesis, differentiation, angiogenesis, and tissue remodeling, as well as pathological processes including inflammation, arthritis, cardiovascular diseases, pulmonary diseases, and tumor invasion. Neutrophil collagenase, also known as Matrix metalloproteinase-8, MMP-8, and CLG1, is a member of the peptidase M1A family. MMP-8 may affect the metastatic behavior of breast cancer cells through protection against lymph node metastasis, underlining the importance of anti-target identification in drug development. MMP-8 in the tumor may have a protective effect against lymph node metastasis. MMP-8 may affect the metastatic behavior of breast cancer cells through protection against lymph node metastasis, underlining the importance of anti-target identification in drug development. MMP-8 participates in wound repair by contributing to the resolution of inflammation and open the possibility to develop new strategies for treating wound healing defects.
Copyright © 2024 Creative Biogene. All rights reserved.